These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4798737)

  • 1. Decrease in morphine's analgesic action and increase in its cataleptic action by 6-hydroxydopamine injected bilaterally into caudate and putamen areas; partial restoration by L-DOPA plus decarboxylase inhibition.
    Nakamura K; Kuntzman R; Maggio A; Conney AH
    Neuropharmacology; 1973 Dec; 12(12):1153-60. PubMed ID: 4798737
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of a permanent and selective depletion of brain catecholamines on the antinociceptive action of morphine.
    Slater P; Blundell C
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Dec; 305(3):227-32. PubMed ID: 740050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of 6-hydroxydopamine on the antinociceptive action of morphine.
    Slater P; Blundell C
    Eur J Pharmacol; 1978 Apr; 48(3):237-47. PubMed ID: 639852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of morphine on striatal dopamine metabolism: possible mechanism of its opposite effect on locomotor activity in rats and mice.
    Kuschinsky K; Hornykiewicz O
    Eur J Pharmacol; 1974 Apr; 26(1):41-50. PubMed ID: 4598755
    [No Abstract]   [Full Text] [Related]  

  • 5. Bilateral injection of kainic acid into the rat striatum potentiates morphine, arecoline and pilocarpine but not haloperidol catalepsy.
    Turski W; Czuczwar SJ; Turski L; Kleinrok Z
    Methods Find Exp Clin Pharmacol; 1982; 4(5):287-91. PubMed ID: 6889661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement by 6-hydroxydopamine of the effects of DOPA upon the motor activity of rats.
    Schoenfeld RI; Uretsky NJ
    J Pharmacol Exp Ther; 1973 Sep; 186(3):616-24. PubMed ID: 4728340
    [No Abstract]   [Full Text] [Related]  

  • 7. Involvement of caudate nucleus, amygdala or reticular formation in neuroleptic and narcotic catalepsy.
    Dunstan R; Broekkamp CL; Lloyd KG
    Pharmacol Biochem Behav; 1981 Feb; 14(2):169-74. PubMed ID: 7193882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relation between spiperone binding, behavioural changes, and in vivo tyrosine hydroxylation in the rat striatum.
    Mjörndal T; Persson SA
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Mar; 322(2):136-9. PubMed ID: 6408490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-dopa induced changes in central monoamine neurons after peripheral decarboxylase inhibition.
    Butcher L; Engel J; Fuxe K
    J Pharm Pharmacol; 1970 Apr; 22(4):313-6. PubMed ID: 4392579
    [No Abstract]   [Full Text] [Related]  

  • 10. Catalepsy and circling behaviour after intracerebral injections of neuroleptic, cholinergic and anticholinergic agents into the caudate-putamen, globus pallidus and substantia nigra of rat brain.
    Costall B; Naylor RJ; Olley JE
    Neuropharmacology; 1972 Sep; 11(5):645-63. PubMed ID: 4597256
    [No Abstract]   [Full Text] [Related]  

  • 11. Infuluence of 6-hydroxydopamine on the effect of morphine on the tail-flick latency.
    Nakamura K; Kuntzman R; Maggio AC; Augulis V; Conney AH
    Psychopharmacologia; 1973 Jul; 31(2):177-89. PubMed ID: 4722208
    [No Abstract]   [Full Text] [Related]  

  • 12. Turning behavior of mice with unilateral 6-hydroxydopamine lesions in the striatum: effects of apomorphine, L-DOPA, amanthadine, amphetamine and other psychomotor stimulants.
    Von Voigtlander PF; Moore KE
    Neuropharmacology; 1973 May; 12(5):451-62. PubMed ID: 4145343
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of LSD and 2-bromo LSD on the striatal DOPA accumulation after decarboxylase inhibition in rats.
    Persson SA
    Eur J Pharmacol; 1977 May; 43(1):73-83. PubMed ID: 16756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 6-OHDA lesion to the dorsal noradrenergic bundle alters morphine-induced locomotor activity and catalepsy.
    Roberts DC; Mason ST; Fibiger HC
    Eur J Pharmacol; 1978 Nov; 52(2):209-14. PubMed ID: 569587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of opiates in striatal D-1 dopamine receptor supersensitivity induced by chronic L-dopa treatment.
    Groppetti A; Ceresoli G; Mandelli V; Parenti M
    J Pharmacol Exp Ther; 1990 Jun; 253(3):950-6. PubMed ID: 2162953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of L-dopa on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats.
    Abercrombie ED; Bonatz AE; Zigmond MJ
    Brain Res; 1990 Aug; 525(1):36-44. PubMed ID: 2123121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of caudate nucleus in dermorphin-induced catalepsy in rats.
    Improta G; Guglietta A
    Peptides; 1985; 6 Suppl 3():161-4. PubMed ID: 3831960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Similarities and differences between D-ALA2 MET5 enkephalin amide and morphine in the induction of tolerance to their effects on catalepsy and on dopamine metabolism in the rat brain.
    De Simoni MG; Guardabasso V; Misterek K; Algeri S
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Nov; 321(2):105-11. PubMed ID: 6891440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial 6-hydroxydopamine-induced lesions and haloperidol-induced catalepsy.
    Johnson SK; Fisher H; Wagner GC
    Neuropharmacology; 1993 Mar; 32(3):273-8. PubMed ID: 8474623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different behavioral responses to L-DOPA after anterolateral or posterolateral hypothalamic injections of 6-hydroxydopamine.
    Ervin GN; Fink JS; Young RC; Smith GP
    Brain Res; 1977 Sep; 132(3):507-20. PubMed ID: 303138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.